USE OF RECOMBINANT ANTIBACTERIAL PROTEIN ABLYSIN FOR EFFECTIVELY KILLING MULTIDRUG-RESISTAN… Application WO-2021002697-A3 World Intellectual Property Organisation (WIPO) 25 Feb 2021